To lead a team developing novel diagnostic services and products for prostate cancer patients
Life Science Partner announces the recruitment of Dr. Gerardo “Jerry” Javier Fernandez, an anatomic pathologist, to Aureon Biosciences.
Aureon is a Yonkers, New York-based company enabling personalized patient care utilizing systems pathology to develop predictive clinical tests for cancer care, as well as to enable biopharmaceutical research and development.
Fernandez was recruited from Genzyme Genetics where he was an anatomic pathologist providing referring physicians with highly specialized referral services. Dr. Fernandez is interested in computer-assisted diagnostics and led the company’s imaging applications and interactive analysis group. Most recently, he was a core team member and the medical consultant for the information system consolidation between laboratory and surgical pathology.
“Jerry is unique in that he is an anatomical pathologist whose keen interest in using computers for improving patient care is his passion,” noted Tom Callaway, MD, founder and president of Life Science Partner. “Aureon will allow him to lead a team developing the latest tool set for cancer diagnostics and turn data into knowledge by the strategic use of computer imaging and integrating patient information.”
Dr. Fernandez will lead a team of four anatomical pathologists interrogating and analyzing tissue to provide the first comprehensive and fully integrated view of the progression of cancer by studying multiple molecular pathways of disease as well as micro-anatomic imaging. By utilizing state-of-the-art informatics, Aureon Biosciences will be able to provide referring physicians some of the first predictive tests for cancer by integrating molecular pathology and clinical informatics.
Dr. Fernandez received his MD from the Medical College of Pennsylvania and his undergraduate degree in Natural Science and Mathematics at Bennington College. He completed his residency in Anatomic/Clinical Pathology and his fellowships in Cytopathology and Surgical Pathology at New York University Medical Center.